Discover how Artificial Intelligence (AI) is reshaping the landscape of drug discovery, ushering in an era of accelerated innovation and efficiency. Explore ten key ways AI is driving transformative changes, from data analysis and virtual screening to clinical trial optimization. Industry leaders, including Andrew Hopkins, CEO of Exscientia, and Dr. Jo Varshney, Chief Medical Officer at AstraZeneca, share insights on AI’s role in revolutionizing the pharmaceutical industry.
AI in drug discovery
Generate Biomedicines, headquartered in Massachusetts, has achieved a groundbreaking leap in protein design through the creation of Chroma, an AI with versatile capabilities.